Venetoclax Dose Escalation Rapidly Activates a BAFF/BCL-2 Survival Axis in Chronic Lymphocytic Leukemia.
Luo MX, Tan T, Trussart M, Poch A, Nguyen MT, Speed TP, Hicks DG, Bandala-Sanchez E, Peng H, Chappaz S, Slade C, Utzschneider DT, Koldej RM, Ritchie D, Strasser A, Thijssen R, Ritchie ME, Tam CSL, Lindeman GJ, Huang DCS Professor, Lew TE, Anderson MA, Roberts AW, Teh CE, Gray DHD.
Luo MX, et al. Among authors: koldej rm.
Blood. 2024 Oct 29:blood.2024024341. doi: 10.1182/blood.2024024341. Online ahead of print.
Blood. 2024.
PMID: 39471335